Tag: MASLD

A major review in The Lancet Regional Health - Europe finds that hepatocellular carcinoma surveillance rests on a single randomised ...

A new review warns that metabolic dysfunction-associated steatotic liver disease in children is independently linked to cardiovascular risk and still ...

A three-decade analysis of U.S. cancer registry data shows that sex and racial disparities in hepatocellular carcinoma incidence have narrowed ...

A major Lancet Regional Health – Europe analysis shows that metabolic liver disease and alcohol are driving a rising tide ...

An integrated study combining NHANES epidemiology, machine learning, single-cell transcriptomics, molecular docking, and mouse experiments links background-level PFOS exposure to ...

A low-molecular-weight polysaccharide extracted from Polygonatum cyrtonema Hua improved glucose control, hepatic steatosis, and gut microbial balance in diabetic mice ...

An international expert panel calls for MASLD to be managed as a systemic cardiometabolic disease, proposing bidirectional heart–liver screening, fibrosis-based ...

A new review finds that structurally distinctive marine polysaccharides can selectively reshape the gut microbiome and its metabolites, offering a ...

A team of researchers in China has uncovered a previously unrecognized molecular pathway that drives metabolic dysfunction-associated steatotic liver disease ...

Vitamin E, one of the most widely studied antioxidant supplements in medicine, has returned to the center of liver research ...